L1 Capital, an investment management firm, released its “L1 Capital International Fund” (unhedged) second quarter 2025 ...

Investment management company Vulcan Value Partners recently released its second-quarter 2025 investor letter. A copy of the ...

UnitedHealth stock is deeply oversold, undervalued, and primed for a recovery. Read why analysts forecast UNH to have a ~29% ...

UnitedHealth Group remains a dominant force within the U.S. healthcare landscape, with a market capitalization of $272.7 billion. The company operates through its two primary arms, UnitedHealthcare ...

According to a recent SEC filing, Ayrshire Capital Management LLC fully liquidated its holding in UnitedHealth Group. The ...

UnitedHealth Group Incorporated (NYSE:UNH) is one of Goldman Sachs’ top healthcare stock picks. On July 10, Wolfe Research ...

UnitedHealth continues to face headwinds due to regulatory scrutiny, Medicare costs, and management changes. Read more on ...

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $150.0 to $460.0 for UnitedHealth Group during the past quarter.

According to a SEC filing dated July 10, Ferguson Wellman Capital Management sold 155,436 shares of UnitedHealth Group( UNH ...

In the assessment of 12-month price targets, analysts unveil insights for UnitedHealth Group, presenting an average target of $425.03, a high estimate of $600.00, and a low estimate of $270.00. This ...

Health Insurance Giant’s Changing Fortunes UnitedHealth Group (NYSE:UNH) is the largest U.S. health insurer by market cap and ...

UnitedHealth is scheduled to report its Q2 earnings on July 29th. Jim Cramer recommends against buying UNH shares until then.